The National Institute for Innovation in Manufacturing Biopharmaceutic

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement
  2. LEWA optimises Bachem's oligonucleotide production through inline dilution system This system allows for a flow rate of 2,500 L per hour, while also enabling flexible buffer production with varying flow rates
  3. AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously
  4. Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
  5. Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Research & Development

$9m goes towards advancing biopharma manufacturing in the US

NIIMBL has selected 15 new technology and talent development projects to advance the field
Regulatory

FDA partners with university on biopharmaceutical manufacturing

Delaware University and the FDA will have the ability to collaborate in a pre-competitive environment
Subscribe now